Who
J. Kevin Buchi
Director
Company insider
Files Form 4 as: Director, Amneal Pharmaceuticals; Director, Benitec Biopharma; Director, Ampio Pharmaceuticals; Director, Dicerna Pharmaceuticals; Director, Alaunos Therapeutics; Chief Executive Officer, Biospecifics Technologies; Director, Impax Laboratories; Director, Alexza Pharmaceuticals.
In numbers
- Trades disclosed
- 209
- Buys
- 14
- Sells
- 5
- Bought
- $2.3M
- Sold
- $9.1M
- Companies
- 13
- Companies where not an officer
- 10
- First trade
- 17 Feb 2006
- Last trade
- 17 Sep 2026
- Last filed
- 21 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Sep 2026filed 21 Sep 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code G | —20,445 at $0.00 | filing |
| 17 Sep 2026filed 21 Sep 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code G | —20,445 at $0.00 | filing |
| 11 Sep 2026filed 14 Sep 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $295K20,445 at $14.45 | filing |
| 11 Sep 2026filed 14 Sep 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —20,445 at $0.00 | filing |
| 11 Sep 2026filed 14 Sep 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —20,445 at $0.00 | filing |
| 11 Sep 2026filed 14 Sep 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $295K20,445 at $14.45 | filing |
| 11 Aug 2026filed 13 Aug 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $2.9M168,573 at $17.18 | filing |
| 11 Aug 2026filed 13 Aug 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $2.9M168,573 at $17.18 | filing |
| 29 Jun 2026filed 30 Jun 2026 | BNTC Benitec BiopharmaBiotechnology | SEC FORM 4 Code G | —51,813 at $0.00 | filing |
| 29 Jun 2026filed 30 Jun 2026 | BNTC Benitec BiopharmaBiotechnology | SEC FORM 4 Code G | —51,813 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —34,819 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —34,819 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —34,819 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —34,819 | filing |
| 6 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,824 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,824 at $0.00 | filing |
| 1 Dec 2025filed 3 Dec 2025 | BNTC Benitec Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 6 May 2025filed 8 May 2025 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —34,819 at $0.00 | filing |
| 5 May 2025filed 8 May 2025 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —40,258 at $0.00 | filing |
| 5 May 2025filed 8 May 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —40,258 | filing |
News
Benitec Biopharma (NASDAQ:BNTC) Stock Breaks Below Fifty Day Moving Average – Here's What HappenedBNTC · tickerreport.com · 10 Oct 2026
0 headlines in the last 90 days name J. Kevin Buchi; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.
Sectors
Related people
Nobody else traded the same names lately.